XML 82 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
9 Months Ended
Sep. 28, 2013
Fair Value Measurements  
Fair Value Measurements

Note 14.  Fair Value Measurements

 

Recurring Fair Value Measurements

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of September 28, 2013:

 

 

 

 

 

Fair Value Measurements Using

(In millions)

 

Total

 

Quoted Prices in
Active Markets
(Level 1)

 

Significant
Other
Observable
Inputs
(Level 2)

 

Significant
Other
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

Available for sale securities

 

$

17.7

 

$

8.1

 

$

9.6

 

$

 

Short-term investments

 

139.6

 

 

139.6

 

 

Derivative assets

 

12.1

 

 

12.1

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

4.8

 

$

.3

 

$

4.5

 

$

 

 

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of December 29, 2012:

 

 

 

 

 

Fair Value Measurements Using

(In millions)

 

Total

 

Quoted Prices in
Active Markets
(Level 1)

 

Significant
Other
Observable
Inputs
(Level 2)

 

Significant
Other
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

Available for sale securities

 

$

18.6

 

$

9.3

 

$

9.3

 

$

 

Derivative assets

 

10.0

 

 

10.0

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

3.8

 

$

1.0

 

$

2.8

 

$

 

 

Available for sale securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value.  As of September 28, 2013, available for sale securities of $.8 million and $17 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets.  As of December 29, 2012, available for sale securities of $.9 million and $17.7 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets.  Short-term investments are comprised of commercial paperand are measured at fair value using broker quoted prices.  As of September 28, 2013, short-term investments were included in “Cash and cash equivalents.”  Derivatives that are exchange-traded are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy.  Derivatives measured based on inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy.

 

Non-recurring Fair Value Measurements

During the nine months ended September 28, 2013, long-lived assets with carrying amounts totaling $8.3 million were written down to their fair value of $4.8 million, resulting in an impairment charge of $3.5 million, which was included in “Other expense, net” in the unaudited Consolidated Statements of Income.  The fair value was based on the sale price of the assets, less estimated broker fees, which are primarily Level 3 inputs.